Form D · Biotechnology
SELEXYS PHARMACEUTICALS CORP
Oklahoma City, OK · CIK 0001442824
Offering snapshot reported Feb 23, 2015 · SEC filing
- Reported sold
- $43.2M Offering amount: $43.2M
- Investors reported
- 57 Form D · investor count
- Minimum accepted
- $13.2K Reported outside-investor minimum
- First sale
- Sep 17, 2012 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$34,459,532 → $43,196,831
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2015 | Amendment | $43,196,831 | $8,737,299vs Oct 2, 2012 | 57 | SEC filing |
| Oct 2, 2012 | Initial | $34,459,532 | No comparison | 57 | SEC filing |
| Nov 4, 2011 | Amendment | $5,000,000 | $4,800,000vs Dec 1, 2010 | 34 | SEC filing |
| Apr 20, 2011 | Amendment | $2,800,000 | $2,600,000vs Dec 1, 2010 | 25 | SEC filing |
| Dec 1, 2010 | Initial | $200,000 | No comparison | 2 | SEC filing |
| Jul 2, 2009 | Amendment | $3,435,000 | No comparison | 31 | SEC filing |
| Aug 12, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184899
Includes warrant issued for $10,000,000, $24,459,532 of Series A Preferred Shares at the initial closing ($10,659,534 of which was from the conversion of outstanding notes), and $8,737,299 of Series A Preferred Shares at the second closing.
Source: Form D, filed Feb 23, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Alvarez | Executive |
| David Falconer | Executive |
| Todd Foley | Director |
| Philip Jones | Director |
| Philip Jones, M.D. | Director |
| David Keiser | Director |
| Rodger Mc Ever | Director |
| Rodger Mc Ever, M.D. | Director |
| William Paiva | Director |
| William Paiva, Ph.D. | Director |
| Scott Rollins | Director, Executive |
| Scott Rollins, Ph.D. | Director, Executive |
| Russell Rother | Executive |
| Tom Walker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
840 Research Parkway Suite 516
Oklahoma City, OK, 73104
Oklahoma City, OK, 73104